pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,125
stories
17d
Electra lights up with $350M IPO for pivotal immune-disease drug development
biospace
18d
This week in charts: GSK’s China deals, the $300M IPO club and selling the news
biopharma dive
18d
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharma dive
18d
Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
biospace
18d
STAT+: Roche expands its Boston footprint with new research center
stat
18d
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
stat
18d
With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’
fiercebiotech
18d
Ultragenyx wins FDA greenlight for first Sanfilippo therapy, priced at nearly $4M
biospace
18d
Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system
fiercebiotech
18d
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
fiercebiotech
18d
Xenon pauses phase 3 depression trials after psychosis events
fiercebiotech
18d
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
fiercebiotech
18d
Inflammation biotech Electra charges up with $350M from upsized IPO
fiercebiotech
18d
Kennedy renews attacks on vaccines at Children’s Health Defense conference
stat
18d
STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
stat
18d
FDA approves Ultragenyx's gene therapy for Sanfilippo syndrome type A
endpoints
18d
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
fda press
18d
Novo partners with Orbis, deepening investment in oral peptide drugs
biopharma dive
19d
Kennedy moves to revive preventive services panel with new members, after months of vacancies
stat
19d
Roche eyes label expansion for Lunsumio after confirmatory lymphoma trial win
endpoints
19d
Rare EGFR mutation increases lung cancer risk 62 times in never smokers
fiercebiotech
19d
Longeveron’s phase 2b stem cell flop spurs cost cutting, exploration of ‘all options’
fiercebiotech
19d
New lawsuit argues NIH violated First Amendment rights of grant applicants
stat
19d
Convergence: EU officials tout pending pharmaceutical reforms
raps
19d
STAT+: GOP aims to change Medicare adviser’s math so it’s more favorable to health insurers
stat
19d
STAT+: Senators highlight the power Chris Klomp wields at confirmation hearings
stat
20d
Deep dive: Psychedelics back on FDA’s doorstep
biospace
20d
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
stat
20d
STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
stat
20d
Skyhawk racks up more support for Huntington’s drug
biopharma dive
← prev
page 6 of 38
next →
